A generic formulation of Zeposia (ozanimod), which won tentative approval for treating multiple sclerosis (MS) from the U.S. Food and Drug Administration (FDA), will be manufactured and supplied by Synthon, based […]
The post New generic version of Zeposia could lower cost of MS treatment appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com